Biomedical Chip Implants for Vision Restoration: Current Status & Research

While biomedical chip implants have advanced, no commercially available implant fully restores sight to the blind. However, ongoing research and clinical trials explore several approaches:

Retinal Implants

Designed for conditions like retinitis pigmentosa or age-related macular degeneration. A camera captures visual information, converts it to electrical signals, and transmits them to an implanted electrode array that stimulates remaining retinal cells, allowing perception of light patterns and shapes. Still in early development; challenges include resolution, biocompatibility, and longevity. Approved only for specific conditions.

Other Research Directions

• Cortical Implants: Stimulate the visual cortex directly, bypassing the retina for potentially broader visual perception.
• Optogenetic Implants: Use light-sensitive proteins engineered into retinal cells to control neural activity with specific light wavelengths.
• Hybrid Implants: Combine retinal and cortical approaches for more comprehensive vision restoration.

Challenges

Safety, long-term functionality, and achieving high-resolution vision remain significant hurdles. These technologies hold great promise but are not yet widely available as treatments for blindness.